Larval zebrafish model for FDA-approved drug repositioning for tobacco dependence treatment.

Larval zebrafish model for FDA-approved drug repositioning for tobacco dependence treatment.

Cigarette smoking remains the most preventable cause of death and excess health care costs in the United States, and is a leading cause of death among alcoholics. Long-term tobacco abstinence rates are low, and pharmacotherapeutic options are limited. Repositioning medications approved by the U.S. F...

Full description

Bibliographic Details
Main Authors: Margot A Cousin, Jon O Ebbert, Amanda R Wiinamaki, Mark D Urban, David P Argue, Stephen C Ekker, Eric W Klee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3962344?pdf=render

Internet

http://europepmc.org/articles/PMC3962344?pdf=render

Similar Items